Somatostatin Analogs Market

May 2021| MRS221A| Market Research Studies

Report Highlights

The scope of this report covers the different types of somatostatin analogs, impact of COVID-19 on the market, and therapies used to treat the various diseases such as, acromegaly, neuroendocrine tumors, carcinoid syndrome, and cushing syndrome. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each by type, application, route of administration, end-user, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional somatostatin analogs markets; it explains the major market drivers of the global somatostatin analogs industry, current trends within the industry, major applications, and the regional dynamics of the global somatostatin analogs market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the Global Somatostatin Analogs Market.

Report Includes

  • 41 tables and 49 figures
  • An up-to-date analysis of the global somatostatin analogs market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for global somatostatin analogs market, and corresponding market share analysis by type, application, route of administration, end-user, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for somatostatin analogs, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new formulations and products still in the development and testing stages, and their probability of successful commercial launch within the next five years.
  • Impact of COVID-19 on the somatostatin analogs market as compared to overall global economy.
  • Insight into the growth development strategies of major somatostatin analogs manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Novartis International AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Camurus AB, Dauntless Pharmaceuticals, Inc., Crinetics Pharmaceuticals, Inc. and others.

Summary

Somatostatin analogs are man-made drugs which are used as a first line treatment for various rare diseases such as, acromegaly, neuroendocrine tumors (NETs), carcinoid syndrome, and cushing syndrome. Besides this, somatostatin analogs are also used to treat VIPoma's, glucagonomas, and GH-secreting tumors. Somatostatin analogs are the drugs which prohibit the secretion of hormone in the body. Somatostatin analogs act by reducing secretion of various growth hormones and serotonin. The secretion of substantial number of hormones by NET leads to carcinoid syndrome. This further controls the symptoms of carcinoid syndrome since somatostatin analogs are the most possible treatment for people suffering with carcinoid syndrome.

According to the American Association of Neurological Surgeons, it is expected that around 10-15 per million people are suffering by Cushing’s syndrome each year. Additionally, the syndrome usually affects adults between the age group of 20-50 years and is relatively more prevalent in case of females than males. Increasing R&D activities and increase prevalence of various diseases such as, acromegaly, neuroendocrine tumors are some of the probable drivers for the market. However, lack of awareness among the people and availability of other treatment options poses as a possible threat for global somatostatin analogs market.

The Global Somatostatin Analogs Market was valued at $6.24 billion in 2020 and is expected to witness a steady growth at a CAGR of 6.49%.

  • Table 0 : Camurus AB: Financial Performance, Through 2020
  • Table 0 : Teva Pharmaceutical Industries Ltd.: Financial Performance, Through 2020
  • Table 0 : Pfizer Inc.: Financial Performance, Through 2020
  • Table 0 : Novartis International AG: Financial Performance, Through 2020
  • Table 0 : Middle East & Africa Somatostatin Analogs Market, by Country, Through 2026
  • Table 0 : Middle East & Africa Somatostatin Analogs Market, by End-User, Through 2026
  • Table 0 : Middle East & Africa Somatostatin Analogs Market, by Route of administration, Through 2026
  • Table 0 : Middle East & Africa Somatostatin Analogs Market, by Application, Through 2026
  • Table 0 : Middle East & Africa Somatostatin Analogs Market, by Type, Through 2026
  • Table 0 : South America Somatostatin Analogs Market, by Country, Through 2026
  • Table 0 : South America Somatostatin Analogs Market, by End-User, Through 2026
  • Table 0 : South America Somatostatin Analogs Market, by Route of administration, Through 2026
  • Table 0 : South America Somatostatin Analogs Market, by Application, Through 2026
  • Table 0 : South America Somatostatin Analogs Market, by Type, Through 2026
  • Table 0 : Asia-Pacific Somatostatin Analogs Market, by Country, Through 2026
  • Table 0 : Asia-Pacific Somatostatin Analogs Market, by End-User, Through 2026
  • Table 0 : Asia-Pacific Somatostatin Analogs Market, by Route of administration, Through 2026
  • Table 0 : Asia-Pacific Somatostatin Analogs Market, by Application, Through 2026
  • Table 0 : Asia-Pacific Somatostatin Analogs Market, by Type, Through 2026
  • Table 0 : Europe Somatostatin Analogs Market, by Country, Through 2026
  • Table 0 : Europe Somatostatin Analogs Market, by End-User, Through 2026
  • Table 0 : Europe Somatostatin Analogs Market, by Route of administration, Through 2026
  • Table 0 : Europe Somatostatin Analogs Market, by Application, Through 2026
  • Table 0 : Europe Somatostatin Analogs Market, by Type, Through 2026
  • Table 0 : North America Somatostatin Analogs Market, by Country, Through 2026
  • Table 0 : North America Somatostatin Analogs Market, by End-User, Through 2026
  • Table 0 : North America Somatostatin Analogs Market, by Route of administration, Through 2026
  • Table 0 : North America Somatostatin Analogs Market, by Application, Through 2026
  • Table 0 : North America Somatostatin Analogs Market, by Type, Through 2026
  • Table 0 : Global Somatostatin Analogs Market, by Region, Through 2026
  • Table 0 : Global Somatostatin Analogs Market, by End-User, Through 2026
  • Table 0 : Global Somatostatin Analogs Market, by Route of administration, Through 2026
  • Table 0 : Global Somatostatin Analogs Market, by Application, Through 2026
  • Table 0 : Global Somatostatin Analogs Market, by Type, Through 2026
  • Table 0 : Global Somatostatin Analogs Market, Through 2026
  • Table 0 : Dauntless Pharmaceuticals, Inc.: Financial Performance, Through 2020
  • Table 0 : Crinetics Pharmaceuticals, Inc.: Financial Performance, Through 2020
  • Table 0 : Peptron, Inc.: Financial Performance, Through 2020
  • Table 0 : Chiasma, Inc.: Financial Performance, Through 2020.
  • Table 0 : Ipsen Pharma SA: Financial Performance, Through 2020
  • Table 0 : Recordati Rare Diseases, Inc.: Financial Performance, Through 2020
  • Figure 1 : Global Somatostatin Analogs Market
  • Figure 2 : Global Somatostatin Analogs Market, by Value, 2019-2026
  • Figure 3 : Global Somatostatin Analogs Market, by Value, by Type, 2019-2026
  • Figure 4 : Global Somatostatin Analogs Market, by Value, by Application, 2019-2026
  • Figure 5 : Global Somatostatin Analogs Market, by Value, by Route of administration, 2019-2026
  • Figure 6 : Global Somatostatin Analogs Market, by Value, by End-User, 2019-2026
  • Figure 7 : Global Somatostatin Analogs Market, by Value, by Region, 2020
  • Figure 8 : Global Somatostatin Analogs Market, by Value, by Company, 2020
  • Figure 9 : Global Somatostatin Analogs Market, Product Map, 2020
  • Figure 10 : North America Somatostatin Analogs Market, by Value, 2019-2026
  • Figure 11 : North America Somatostatin Analogs Market, by Value, by Type, 2019-2026
  • Figure 12 : North America Somatostatin Analogs Market, by Value, by Application, 2019-2026
  • Figure 13 : North America Somatostatin Analogs Market, by Value, by Route of administration, 2019-2026
  • Figure 14 : North America Somatostatin Analogs Market, by Value, by End-User, 2019-2026
  • Figure 15 : North America Somatostatin Analogs Market, by Value, by Country, 2020
  • Figure 16 : Europe Somatostatin Analogs Market, by Value, 2019-2026
  • Figure 17 : Europe Somatostatin Analogs Market, by Value, by Type, 2019-2026
  • Figure 18 : Europe Somatostatin Analogs Market, by Value, by Application, 2019-2026
  • Figure 19 : Europe Somatostatin Analogs Market, by Value, by Route of administration, 2019-2026
  • Figure 20 : Europe Somatostatin Analogs Market, by Value, by End-User, 2019-2026
  • Figure 21 : Europe Somatostatin Analogs Market, by Value, by Country, 2020
  • Figure 22 : Asia-Pacific Somatostatin Analogs Market, by Value, 2019-2026
  • Figure 23 : Asia-Pacific Somatostatin Analogs Market, by Value, by Type, 2019-2026
  • Figure 24 : Asia-Pacific Somatostatin Analogs Market, by Value, by Application, 2019-2026
  • Figure 25 : Asia-Pacific Somatostatin Analogs Market, by Value, by Route of administration, 2019-2026
  • Figure 26 : Asia-Pacific Somatostatin Analogs Market, by Value, by End-User, 2019-2026
  • Figure 27 : Asia-Pacific Somatostatin Analogs Market, by Value, by Country, 2020
  • Figure 28 : South America Somatostatin Analogs Market, by Value, 2019-2026
  • Figure 29 : South America Somatostatin Analogs Market, by Value, by Type, 2019-2026
  • Figure 30 : South America Somatostatin Analogs Market, by Value, by Application, 2019-2026
  • Figure 31 : South America Somatostatin Analogs Market, by Value, by Route of administration, 2019-2026
  • Figure 32 : South America Somatostatin Analogs Market, by Value, by End-User, 2019-2026
  • Figure 33 : South America Somatostatin Analogs Market, by Value, by Country, 2020
  • Figure 34 : Middle East & Africa Somatostatin Analogs Market, by Value, 2019-2026
  • Figure 35 : Middle East & Africa Somatostatin Analogs Market, by Value, by Type, 2019-2026
  • Figure 36 : Middle East & Africa Somatostatin Analogs Market, by Value, by Application, 2019-2026
  • Figure 37 : Middle East & Africa Somatostatin Analogs Market, by Value, by Route of administration, 2019-2026
  • Figure 38 : Middle East & Africa Somatostatin Analogs Market, by Value, by End-User, 2019-2026
  • Figure 39 : Middle East & Africa Somatostatin Analogs Market, by Value, by Country, 2020
  • Figure 40 : Novartis International AG: Revenue Share, 2020
  • Figure 41 : Pfizer Inc.: Revenue Share, 2020
  • Figure 42 : Teva Pharmaceutical Industries Ltd.: Revenue Share, 2020
  • Figure 43 : Camurus AB: Revenue Share, 2020
  • Figure 44 : Dauntless Pharmaceuticals, Inc.: Revenue Share, 2020
  • Figure 45 : Crinetics Pharmaceuticals, Inc.: Revenue Share, 2020
  • Figure 46 : Peptron, Inc.: Revenue Share, 2020
  • Figure 47 : Chiasma, Inc.: Revenue Share, 2020
  • Figure 48 : Ipsen Pharma SA: Revenue Share, 2020
  • Figure 49 : Recordati Rare Diseases, Inc.: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report